<DOC>
	<DOCNO>NCT00001270</DOCNO>
	<brief_summary>This phase I/II study interleukin-1 , G-CSF high dose ICE chemotherapy autologous bone marrow transplant patient relapse breast , testicular lymphoid cancer . The initial goal study define toxicity interleukin-1 administer 7 day prior ICE chemotherapy . A total 22 patient treat IL-1 ICE result show rapid engraftment ( 4.5 day ) IL-1 . A second cohort 18 patient also receive G-CSF engraftment shorten subgroup . Overall , median time engraftment 16 day IL-1 G-CSF . Accrual continue define toxicity efficacy regimen .</brief_summary>
	<brief_title>Feasibility Study Interleukin 1-Alpha With Ifosfamide , CBDCA , Etoposide With Autologous Bone Marrow Transplant Metastatic Carcinoma Lymphoma</brief_title>
	<detailed_description>This phase I/II study interleukin-1 , G-CSF high dose ICE chemotherapy autologous bone marrow transplant patient relapse breast , testicular lymphoid cancer . The initial goal study define toxicity interleukin-1 administer 7 day prior ICE chemotherapy . A total 22 patient treat IL-1 ICE result show rapid engraftment ( 4.5 day ) IL-1 . A second cohort 18 patient also receive G-CSF engraftment shorten subgroup . Overall , median time engraftment 16 day IL-1 G-CSF . Accrual continue define toxicity efficacy regimen .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>A history pathologically document ( clinical documentation may acceptable relapse ) : Breast cancer : metastatic locally advanced ( Stage III/IV ) stable minimal ( less equal 2 cm ) residual disease 2 cycle appropriate combination chemotherapy may start BMT . NonHodgkin 's lymphoma : stage relapse induction failure ( FSC , FM , FL , DSC , DL , DM , DIDL , IBL , LBL , SNC ) appropriate chemotherapy . Hodgkin 's lymphoma : stage chemotherapy induction failure , first relapse less equal 1 year chemotherapy induce remission , first relapse great 1 year chemotherapy induce remission extranodal involvement relapse , great equal 2 relapse ( one may radiation ) follow appropriate combination chemotherapy , relapse time radiation therapy stage IIB , IIIB , IV A/B . Testicular cancer : stage relapse induction failure follow appropriate combination chemotherapy . No evidence central nervous system cancer . Patients must 18 65 year old . Normal cardiac function : history angina pectoris , myocardial infarction , congestive heart failure ejection fraction le 40 percent . Creatinine clearance great equal 45 cc/min/m ( 2 ) , bilirubin less equal 1.5 , SGOT le equal 2x normal , normal PT , PTT calcium . Negative HIV serology hepatitis B surface antigen . Adequate pulmonary function ( PFTs obtain patient clinical evidence pulmonary dysfunction ) : DLCO great 50 percent , compensate Hgb , FEV 1 great 55 percent PO2 great 60 . Negative bilateral bone marrow biopsy prior bone marrow harvest . No evidence metastatic disease pelvis plain film bone scan . Karnofsky performance status great equal 70 life expectancy great equal 60 day . No evidence pregnancy risk pregnancy time transplantation woman . Ability give inform consent . Good psychiatric medical risk .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>Chemotherapy</keyword>
	<keyword>High Dose</keyword>
	<keyword>Protection</keyword>
</DOC>